Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Congenica

Congenica?uq=U5Zpp9ZJ
2012 FOUNDED
PRIVATE STATUS
31-40 EMPLOYEES
Series B LATEST DEAL TYPE
$10.2M LATEST DEAL AMOUNT
9 INVESTORS
Description

Developer of a clinical genome analysis platform designed to identify genetic diseases in patients. The company's platform processes genomic data sets to detect mutations by filtering clinically relevant variants and deep clinical phenotyping, enabling clinicians to provide actionable interpretation of genetic disease for patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Decision/Risk Analysis
Other Healthcare Technology Systems
Primary Office
  • Wellcome Trust Genome Campus
  • Hinxton
  • Cambridge CB10 1DR
  • England

+44 01223 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Congenica’s full profile, request a free trial.

Congenica Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series B) 27-Apr-2017 $10.2M 000.00 000.00 Completed Generating Revenue
5. Grant 29-Sep-2015 00000 00.000 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Apr-2015 00.000 00.000 00.000 Completed Generating Revenue
3. Grant 11-Mar-2015 00.00 00.000 Completed Startup
2. Seed Round 05-Dec-2014 $2.44M $2.44M Completed Startup
1. Grant 02-May-2014 $573K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Congenica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
B Ordinary 0,000,000 00.00 00.00 00 00.00 00.000
A Ordinary 0,000,000 00.00 00.00 00 00.00 00.000
A Ordinary 000,000 00.00 00.00 00 00.00 00
A Ordinary 3,996,428 $0.63 $0.63 1x $0.63 20.02%
A Ordinary 2,553,500 $0.25 $0.25 1x $0.25 12.79%
To view this company’s complete Cap Table, request access »

Congenica Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
BGI VC-Backed Company Minority 000 0000 000000 0
Future Planet Capital Growth/Expansion Minority 000 0000 000000 0
Healthlink Capital Other Minority 000 0000 000000 0
Parkwalk Advisors Venture Capital Minority 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Congenica Executive Team (16)

Name Title Board
Seat
Contact
Info
David Atkins Ph.D Chief Executive Officer & Board Member
Wendy Britten Chief Financial Officer
Nicholas Lench Ph.D Chief Scientific Officer & Board Member
Peter Fox Chief Technology Officer
Philip Beales Medical Director & Board Member

7 Former Executives

You’re viewing 5 of 16 executives. Get the full list »

Congenica Board Members (14)

Name Representing Role Since Contact
Info
Alastair Kilgour Parkwalk Advisors Board Member 000 0000
Andrew Richards Congenica Chairman 000 0000
David Atkins Ph.D Congenica Chief Executive Officer & Board Member 000 0000
Hermann Hauser Ph.D Amadeus Capital Partners Board Member 000 0000
Matthew Hurles Congenica Scientific Director & Board Member 000 0000

4 Former Board Members

You’re viewing 5 of 14 board members. Get the full list »